Opioid Over-Prescription after Mesh-Based, Outpatient Ventral Hernia Repair (Quick-Shot)
Document Type
Conference Proceeding
Publication Date
10-20-2024
Abstract
Introduction: Despite efforts to minimize opioid prescribing, ventral hernia repair (VHR) with mesh remains notoriously painful, often requiring postoperative opioid analgesia. Here, we aim to characterize patterns of opioid prescribing for the heterogenous group of patients and procedures that comprise mesh-based, outpatient VHR.
Methods: The Abdominal Core Health Quality Collaborative registry was queried for patients undergoing VHR with mesh who were discharged the same or next day between 1/2019-10/2023. Procedures were broadly classified by approach and mesh location: open, minimally-invasive (robotic or laparoscopic) with intraperitoneal mesh (MIP), and minimally-invasive with retromuscular or preperitoneal mesh (MRPP). Surgeon-reported opioid prescription quantity and patient-reported 30-day consumption data were reviewed.
Results: Of 2795 patients who met inclusion criteria (46.1% open, 22.7% MIP, 31.2% MRPP), approximately 80% of patients consumed ≤10 tablets of opioid pain medication (open 87.7%, MIP 78.4%, MRPP 84.2% - Table 1). For patients who were prescribed ≤10 tablets, the median number of unconsumed tablets was 5 (IQR 0-8). For patients who were prescribed >10 tablets, the median number of unconsumed tablets was 10 or more (open 10[IQR 2-16], MIP 10[IQR 2-18], MRPP 12[IQR 5-16]). The number of tablets consumed was positively correlated with the number of tablets prescribed (Kendall's rank correlation = 0.232, p<0.001).
Recommended Citation
Woo KP, Zheng X, Goel AP, Higgins R, Iacco AA, Harris TS et al Opioid over-prescription after mesh-based, outpatient ventral hernia repair (quick-shot). Presented at: American College of Surgeons Clinical Conference; 2024 Oct 20; San Francisco, CA.
Comments
The Clinical Congress of the American College of Surgeons, San Francisco, CA, October 19-22, 2024.